Literature DB >> 17300670

Tumor suppressor in lung cancer-1 as a novel ameloblast adhesion molecule and its downregulation in ameloblastoma.

Yu Usami1, Akihiko Ito, Kazuhiro Ohnuma, Takeichi Fuku, Takahide Komori, Hiroshi Yokozaki.   

Abstract

Tumor suppressor in lung cancer-1 (TSLC1) is an intercellular adhesion molecule of the immunoglobulin superfamily. There is little information regarding the developmental expression profiles. In an attempt to clarify the distribution of TSLC1 proteins in mouse embryos tissue by immunohistochemistry, it was found that the TSLC1-specific signals were detected in the tooth germ as early as bud stage. The signals of TSLC1 were in the enamel epithelium at the cap stage, and became restricted to ameloblasts during the transition to and throughout the bell stage. In contrast, the signals for E-cadherin, which is important in odontogenesis, were distributed in all the components of the ectoderm-derived germ at any stage. In addition, E-cadherin preferred to locate on the basal membrane of ameloblasts, whereas TSLC1 preferred the lateral. And in further contrast, all the ameloblastomas examined were positive for E-cadherin (18/18) whereas all but one was negative for TSLC1 (1/18). These results indicate that TSLC1 is a novel interameloblast adhesion molecule that may be downregulated during ameloblastic tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17300670     DOI: 10.1111/j.1440-1827.2006.02064.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  1 in total

1.  Tumor suppressor TSLC1 is implicated in cell proliferation, invasion and apoptosis in laryngeal squamous cell carcinoma by regulating Akt signaling pathway.

Authors:  Baocai Lu; Wenyu Di; Huimin Wang; Huimin Ma; Jinsong Li; Qunmei Zhang
Journal:  Tumour Biol       Date:  2012-07-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.